Overview

The Effectiveness and Safety of 4% Sodium Citrate as a Lock Solution in Central Venous Hemodialysis Catheter

Status:
Enrolling by invitation

Trial end date:
2022-07-01

Target enrollment:

Participant gender:

Summary

Studies that used a dilute citrate formulation (4%) demonstrated efficacy as an anticoagulant with minimal to no risk of bleeding in HD sessions. This study will compare effectiveness and safety utilizing 4% sodium citrate vs. heparin as a lock solution in central venous hemodialysis catheter among hemodialysis patients.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Chang Gung Memorial Hospital

Treatments:

Citric Acid
Sodium Citrate